SARS-CoV-2 infection in patients with diabetes mellitus and hypertension: a systematic review

被引:10
作者
Deravi, Niloofar [1 ]
Fathi, Mobina [1 ]
Vakili, Kimia [1 ]
Yaghoobpoor, Shirin [1 ]
Pirzadeh, Marzieh [2 ]
Mokhtari, Melika [3 ]
Fazel, Tara [4 ]
Ahsan, Elahe [1 ]
Ghaffari, Samad [5 ]
机构
[1] Shahid Beheshti Univ Med Sci, Sch Med, Student Res Comm, Tehran 1983969411, Iran
[2] Babol Univ Med Sci, Student Res Comm, Babol 4717647745, Iran
[3] Islamic Azad Univ, Student Res Comm, Fac Dent, Tehran Med Sci, Tehran 1946853314, Iran
[4] Guilan Univ Med Sci, Sch Int Campus, Student Res Comm, Rasht 4199613776, Iran
[5] Tabriz Univ Med Sci, Cardiovasc Res Ctr, Tabriz 5166616471, Iran
关键词
Diabetes mellitus; hypertension; SARS-CoV-2; COVID-19; MERS; SARS; RESPIRATORY SYNDROME-CORONAVIRUS; ANGIOTENSIN-CONVERTING ENZYME; INTENSIVE INSULIN THERAPY; CLINICAL CHARACTERISTICS; FUNCTIONAL RECEPTOR; MERS-COV; L-SIGN; MACROPHAGE INFILTRATION; SARS CORONAVIRUS; CRITICALLY-ILL;
D O I
10.31083/j.rcm.2020.03.78
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
After the emergence of the novel 2019 coronavirus disease in P. R. China, this highly contagious disease has been currently spread out to almost all countries, worldwide. Novel 2019 coronavirus disease, Middle East respiratory syndrome, and severe acute respiratory syndrome are reported to cause a higher risk for severe infections in patients with chronic comorbidities, such as hypertension and diabetes. These severe infections can contribute to higher rates of morbidity and mortality in these patients. In the present review, we discussed the role and underlying mechanisms of the two most common chronic diseases, type-2 diabetes mellitus and hypertension, in clinical manifestations and disease severity of novel 2019 coronavirus disease, Middle East respiratory syndrome and severe acute respiratory syndrome, with the hope to provide evidence for better decision-making in the treatment of this vulnerable population.
引用
收藏
页码:385 / 397
页数:13
相关论文
共 146 条
[11]  
Bataillard A, 1995, J HYPERTENS, V13, P1581
[12]   Influence of diabetes and hyperglycaemia on infectious disease hospitalisation and outcome [J].
Benfield, T. ;
Jensen, J. S. ;
Nordestgaard, B. G. .
DIABETOLOGIA, 2007, 50 (03) :549-554
[13]   Diabetes and COVID-19 [J].
Bloomgarden, Zachary T. .
JOURNAL OF DIABETES, 2020, 12 (04) :347-348
[14]  
Bornstein S, 2020, NATURE REV ENDOCRINO, V16, P1
[15]   DC/L-SIGNs of hope in the COVID-19 pandemic [J].
Brufsky, Adam ;
Lotze, Michael T. .
JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (09) :1396-1398
[16]   Hyperglycemia, hydroxychloroquine, and the COVID-19 pandemic [J].
Brufsky, Adam .
JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (07) :770-775
[17]   CC chemokine receptor 2 is required for macrophage infiltration and vascular hypertrophy in angiotensin II-induced hypertension [J].
Bush, E ;
Maeda, N ;
Kuziel, WA ;
Dawson, TC ;
Wilcox, JN ;
DeLeon, H ;
Taylor, WR .
HYPERTENSION, 2000, 36 (03) :360-363
[18]  
Casqueiro Juliana, 2012, Indian J Endocrinol Metab, V16 Suppl 1, pS27, DOI 10.4103/2230-8210.94253
[19]   SARS: Epidemiology [J].
Chan-Yeung, M ;
Xu, RH .
RESPIROLOGY, 2003, 8 :S9-S14
[20]   Individual variation of the SARS-CoV-2 receptor ACE2 gene expression and regulation [J].
Chen, Jiawei ;
Jiang, Quanlong ;
Xia, Xian ;
Liu, Kangping ;
Yu, Zhengqing ;
Tao, Wanyu ;
Gong, Wenxuan ;
Han, Jing-Dong J. .
AGING CELL, 2020, 19 (07)